Kura Oncology
KURA
44 hedge funds and large institutions have $101M invested in Kura Oncology in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 10 closing their positions.
90% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 10
86% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 7
26% more funds holding
Funds holding: 35 → 44 (+9)
11% more capital invested
Capital invested by funds: $90.7M → $101M (+$9.83M)
2.3% more ownership
Funds ownership: 48.2% → 50.51% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.06M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.36M |
| 3 |
Morgan Stanley
New York
|
+$1.29M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.21M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$455K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$5.26M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$726K |
| 3 |
Goldman Sachs
New York
|
-$533K |
| 4 |
Millennium Management
New York
|
-$355K |
| 5 |
Squarepoint
New York
|
-$196K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| – | -$23K | -2,639 | Closed |
|
|
AIM
52
Acrospire Investment Management
Chicago,
Illinois
| – | -$8K | -900 | Closed |
|
|
MA
53
MUFG Americas
New York
| – | -$5K | -550 | Closed |
|
54
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$46 | -5 | -71% |
|
KURA Hedge Fund Activity: Q2 2017 in Review
44 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2017, worth a combined $101M — up 11% from $90.7M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new KURA positions and 10 closed out — a net gain of 9 holders — while 13 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $5.06M. The largest seller was EcoR1 Capital, cutting an estimated $5.26M.
- 44 institutional investors held Kura Oncology (KURA) as of Q2 2017, up from 35 in Q1 2017.
- Funds reported $101M of Kura Oncology stock for Q2 2017, up 11% quarter-over-quarter.
- 19 funds opened new Kura Oncology positions in Q2 2017 and 10 closed out, a net change of +9 holders.
- The largest Kura Oncology buyer in Q2 2017 was BlackRock, an estimated $5.06M added.
- The largest Kura Oncology seller in Q2 2017 was EcoR1 Capital, an estimated $5.26M sold.
Based on aggregated 13F filings for Q2 2017.